U.S. Markets close in 35 mins

A Financial Overview of Ionis Pharmaceuticals in October

Daniel Collins
A Financial Overview of Ionis Pharmaceuticals in October

Ionis Pharmaceuticals generated second-quarter revenues of $118.0 million compared to $122.3 million in the second quarter of 2017, which reflected ~15.0% YoY (year-over-year) growth. In the first half, Ionis Pharmaceuticals reported revenues of $262.2 million, compared to $228.1 million in the first half of 2017.